[FDMT] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[FDMT] 4D Molecular Therapeutics, Inc.
Announcement Date
09-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -8.65%
YoY- -8.06%
Quarter Report
FDMT's Result
FDMT's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 5 239 162 14,580 3,633 2,208 2,535 -64.55%
PBT -34,953 -29,616 -28,086 -7,589 -15,153 -8,258 -2,593 54.20%
Tax 0 -1,428 -680 0 -14 0 0 -
NP -34,953 -29,616 -27,406 -7,589 -15,153 -8,258 -2,593 54.20%
Tax Rate - - - - - - - -
Total Cost 34,958 29,855 27,568 22,169 18,786 10,466 5,128 37.65%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -699,060.00 -12,391.63 -16,917.28 -52.05 -417.09 -374.00 -102.31 335.02%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.63 -0.77 -0.85 -0.28 -1.02 -1.61 -0.52 3.24%
EPS Diluted -0.63 -0.77 -0.85 -0.28 -1.02 -1.61 -0.52 3.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.